News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STUELPNAGEL JOHN R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/07/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 10,000 shares
@ $54.8894, valued at
$548.9k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 3,218 shares
@ $150.5596, valued at
$484.5k
Sold 1,782 shares
@ $151.565, valued at
$270.1k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 800 shares
@ $157.5481, valued at
$126k
Sold 3,052 shares
@ $158.7888, valued at
$484.6k
Sold 1,048 shares
@ $159.8019, valued at
$167.5k
Sold 100 shares
@ $160.32, valued at
$16k
|
|
| 11/03/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 100 shares
@ $160.33, valued at
$16k
Sold 100 shares
@ $160.75, valued at
$16.1k
Sold 100 shares
@ $161.52, valued at
$16.2k
Sold 1,494 shares
@ $163.0985, valued at
$243.7k
Sold 2,906 shares
@ $163.8899, valued at
$476.3k
Sold 300 shares
@ $164.58, valued at
$49.4k
|
|
| 10/20/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 4,400 shares
@ $150.5136, valued at
$662.3k
Sold 300 shares
@ $151.4133, valued at
$45.4k
Sold 300 shares
@ $152.1968, valued at
$45.7k
|
|
| 10/12/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 5,000 shares
@ $150.1798, valued at
$750.9k
|
|
| 09/20/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 700 shares
@ $154.4529, valued at
$108.1k
Sold 1,500 shares
@ $155.689, valued at
$233.5k
Sold 1,631 shares
@ $156.7217, valued at
$255.6k
Sold 1,169 shares
@ $157.7455, valued at
$184.4k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,100 shares
@ $178.4759, valued at
$196.3k
Sold 1,140 shares
@ $179.5341, valued at
$204.7k
Sold 960 shares
@ $180.3281, valued at
$173.1k
Sold 1,100 shares
@ $181.4724, valued at
$199.6k
Sold 400 shares
@ $182.74, valued at
$73.1k
Sold 200 shares
@ $183.9, valued at
$36.8k
Sold 100 shares
@ $184.99, valued at
$18.5k
|
|
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,600 shares
@ $189.943, valued at
$303.9k
Sold 1,300 shares
@ $190.8669, valued at
$248.1k
Sold 700 shares
@ $191.9734, valued at
$134.4k
Sold 700 shares
@ $193.5064, valued at
$135.5k
Sold 500 shares
@ $194.2869, valued at
$97.1k
Sold 200 shares
@ $196, valued at
$39.2k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,400 shares
@ $175.7879, valued at
$246.1k
Sold 900 shares
@ $176.5667, valued at
$158.9k
Sold 1,110 shares
@ $178.3111, valued at
$197.9k
Sold 1,608 shares
@ $179.2819, valued at
$288.3k
Sold 1,206 shares
@ $180.2707, valued at
$217.4k
Sold 900 shares
@ $181.4922, valued at
$163.3k
Sold 376 shares
@ $182.7821, valued at
$68.7k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,101 shares
@ $146.7815, valued at
$161.6k
Sold 2,200 shares
@ $147.6839, valued at
$324.9k
Sold 3,098 shares
@ $148.5048, valued at
$460.1k
Sold 801 shares
@ $149.3548, valued at
$119.6k
Sold 300 shares
@ $151.2367, valued at
$45.4k
|
|
| 12/03/2020 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 2,100 shares
@ $150.1461, valued at
$315.3k
Sold 3,500 shares
@ $150.9887, valued at
$528.5k
Sold 500 shares
@ $151.676, valued at
$75.8k
Sold 500 shares
@ $152.88, valued at
$76.4k
Sold 900 shares
@ $153.5367, valued at
$138.2k
|
|
| 11/19/2020 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 400 shares
@ $133.175, valued at
$53.3k
Sold 1,576 shares
@ $135.4061, valued at
$213.4k
Sold 4,424 shares
@ $136.1946, valued at
$602.5k
Sold 1,100 shares
@ $136.9701, valued at
$150.7k
|
|
| 11/04/2020 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 2,328 shares
@ $135.6197, valued at
$315.7k
Sold 3,900 shares
@ $136.2297, valued at
$531.3k
Sold 772 shares
@ $137.473, valued at
$106.1k
Sold 500 shares
@ $139.034, valued at
$69.5k
|
|
| 10/20/2020 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 4,499 shares
@ $163.9869, valued at
$737.8k
Sold 3,001 shares
@ $164.6649, valued at
$494.2k
|
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|